A Study of LY3819469 in Healthy Participants

NCT04914546 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3819469
DRUG: Placebo

Sponsor

Eli Lilly and Company